Cargando…
Exploring Risks of Human Challenge Trials For COVID‐19
Human challenge trials (HCTs) are a potential method to accelerate development of vaccines and therapeutics. However, HCTs for COVID‐19 pose ethical and practical challenges, in part due to the unclear and developing risks. In this article , we introduce an interactive model for exploring some risks...
Autores principales: | Manheim, David, Wiȩcek, Witold, Schmit, Virginia, Morrison, Josh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207107/ https://www.ncbi.nlm.nih.gov/pubmed/33942351 http://dx.doi.org/10.1111/risa.13726 |
Ejemplares similares
-
A Systematic Review of Human Challenge Trials, Designs, and Safety
por: Adams-Phipps, Jupiter, et al.
Publicado: (2022) -
Evolving ethics of COVID-19 challenge trials
por: Manheim, David
Publicado: (2021) -
Managing the Transition to Widespread Metagenomic Monitoring: Policy Considerations for Future Biosurveillance
por: Liang, Chelsea, et al.
Publicado: (2023) -
Characterizing altruistic motivation in potential volunteers for SARS-CoV-2 challenge trials
por: Marsh, Abigail A., et al.
Publicado: (2022) -
High-risk human-caused pathogen exposure events from 1975-2016
por: Manheim, David, et al.
Publicado: (2022)